BILL REQ. #: S-3626.3
State of Washington | 59th Legislature | 2006 Regular Session |
Read first time 01/13/2006. Referred to Committee on Water, Energy & Environment.
AN ACT Relating to biomonitoring; adding a new chapter to Title 70 RCW; creating a new section; making an appropriation; and providing an effective date.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON:
NEW SECTION. Sec. 1 (1) The legislature finds that:
(a) About seven out of every ten deaths in the United States are
attributable to chronic diseases. About one hundred twenty-five
million people have at least one chronic illness while sixty million
suffer from multiple chronic illnesses. About twenty million children
in the country have at least one chronic health problem;
(b) Chronic illnesses impose enormous health care and other costs
upon Washington. For example, the estimated total cost of asthma in
the state is about four hundred million dollars annually. Special
education for the estimated one hundred twenty thousand children in the
state's schools with learning disabilities costs about four hundred
seventy million dollars each year;
(c) There are an estimated eighty-five thousand chemicals
registered for use today in the United States, with another two
thousand added each year. Some toxicological screening data exists for
only seven percent of these chemicals. More than ninety percent of
these chemicals have never been tested for their effects on human
health. Large numbers of these chemicals are found in cosmetics,
personal care products, pesticides, food dyes, cleaning products,
fuels, and plastics. Because of their ubiquity in modern life,
Washington residents are commonly exposed to multiple chemicals every
day. Many of these chemicals persist in the environment, and
accumulate and remain in body fat, and have been shown to be toxic.
Persistent, bioaccumulative, toxics (PBTs) have been targeted by the
state of Washington, the federal government, and other nations around
the world for actions to reduce the impact of PBTs on human health and
the environment;
(d) Biomonitoring data supports public health by establishing
trends in chemical exposures, validating modeling and survey methods,
supporting epidemiological studies, identifying affected communities,
assisting in emergency health responses to unanticipated emergency
exposures, assessing the effectiveness of current regulations, and
helping to set priorities for chemical exposure reduction strategies;
(e) A grant from the federal Centers for Disease Control enabled
the Washington department of health, through the assistance of an
advisory committee of public health professionals, to develop a
biomonitoring plan, completed in 2003, that identifies the high
priorities for the chemicals, environmental settings, and populations
for monitoring. However, Washington did not receive federal funding
for the implementation of this plan and to date no funding has been
identified to move forward with any portion of this plan;
(f) The Washington environmental public health tracking network is
working to improve the state of information concerning environmental
contaminants, human exposure to hazards, and potentially related health
outcomes statewide. The program is developing network infrastructure
to integrate environmental and public health information systems,
improve the completeness and timeliness of data for monitoring health
outcomes attributable to environmental hazards and exposures, and
improve access to information in those data systems.
(2) It is therefore the purpose of this chapter to authorize a
biomonitoring program in Washington as an integral part of the
environmental public health tracking network, to secure initial funding
for implementing the highest priority elements of the program, and to
identify a long-term funding source for implementing the balance of the
priorities identified in 2003.
NEW SECTION. Sec. 2 The definitions in this section apply
throughout this chapter unless the context clearly requires otherwise.
(1) "Department" means the department of health.
(2) "Biomonitoring" means the process by which the presence and
concentration of toxic chemicals and their metabolites are identified
within a biospecimen as a means to assess the chemical body burden.
(3) "Biospecimen" means a sample taken from a biophysical
substance, that is reasonably available within a human body, for use as
a medium to measure the presence and concentration of toxic chemicals.
NEW SECTION. Sec. 3 (1) The department shall conduct
biomonitoring as an element of the environmental health tracking
program administered by the department. The biomonitoring shall be
conducted in collaboration with the department of ecology, local health
jurisdictions, and other public health agencies with the objective of
assisting public health agencies and policymakers in allocating
resources to maximize environmental health improvements.
(2) The department shall adopt guidelines and model protocols to
guide local and state agencies conducting biomonitoring and that are
consistent with the requirements and priorities of this chapter. The
guidelines and model protocols shall address, without limitation, the
following:
(a) Ensuring confidentiality and informed consent, and
communicating findings to participants, communities, and the general
public;
(b) Emphasizing that all aspects of the program are culturally
sensitive; and
(c) When communicating with participants regarding the purposes of
biomonitoring and the uses of biomonitoring results and data, providing
a clear explanation of the distinction between exposure data and
analysis of the health effects that may occur from chemical exposures.
(3) In selecting biomonitoring measurements, the department shall
accord a priority to:
(a) Measuring the prevalence of elevated levels of toxic substances
in a population group;
(b) Determining levels of exposure in population groups that may be
at increased risk of exposure;
(c) Providing information on levels of human exposure for studies
examining the relationship between exposure to a toxic substance and
adverse health effects;
(d) Tracking the trends in levels of exposure of a population group
to specific toxic substances; and
(e) Assessing effectiveness of public health efforts to reduce the
exposure of specific populations to toxic substances.
NEW SECTION. Sec. 4 Sections 1 through 3 of this act constitute
a new chapter in Title
NEW SECTION. Sec. 5 By September 30, 2006, the department of
health, in consultation with the department of ecology and local health
jurisdictions, shall provide recommendations to the governor and the
appropriate committees of the senate and house of representatives for
funding the biomonitoring program. The recommendations shall provide
a proposed phase-in of the top ten highest priorities identified by the
department of health's 2003 biomonitoring plan, and shall include
recommendations for sharing of costs among federal, state, local, and
nongovernmental entities. The department of health's implementation
recommendations shall include the objective of integrating with and
complementing nationwide monitoring programs.
NEW SECTION. Sec. 6 Sections 2 and 3 of this act take effect
July 1, 2007.
NEW SECTION. Sec. 7 The sum of fifty thousand dollars, or as
much thereof as may be necessary, is appropriated for the biennium
ending June 30, 2007, from the state toxics control account to the
department of health for the purposes of this act.